Evaluating the World Health Organization’s Hearts Model for Hypertension and Diabetes Management: A Pilot Implementation Study in Guatemala
References
- WHO. WHO package of essential noncommunicable (PEN) disease interventions for primary health care. Geneva: World Health Organization; 2020.
- WHO. Hearts: Technical package for cardiovascular disease management in primary health care. Geneva: World Health Organization; 2016.
- Ordunez P, Campbell NR, Giraldo Arcila GP, et al. HEARTS in the Americas: Innovations for improving hypertension and cardiovascular disease risk management in primary care. Rev Panam Salud Publica. 2022; 46:
e96 . DOI: 10.26633/RPSP.2022.96 - Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 395(10226):795–808. DOI: 10.1016/S0140-6736(19)32008-2
- WHO. Improving hypertension control in 3 million people: country experiences of programme development and implementation. Geneva: World Health Organization; 2020.
- Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
- Flood D, Edwards EW, Giovannini D, et al. Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool. Rev Panam Salud Publica. 2022; 46:
e150 . DOI: 10.26633/RPSP.2022.150 - Wellmann IA, Ayala LF, Rodriguez JJ, et al. Implementing integrated hypertension and diabetes management using the World Health Organization’s HEARTS model: Protocol for a pilot study in the Guatemalan national primary care system. Implement Sci Commun. 2024; 5(1):7. DOI: 10.1186/s43058-023-00539-8
- United States Census Bureau. Guatemala; 2023 [Cited 2023 Sep 15]. Available from:
https://www.census.gov/popclock/world/gt . - Institute for Health Metrics and Evaluation. GBD Compare. Viz Hub; 2024. (cited 2024 April 24). Available at:
https://vizhub.healthdata.org/gbd-compare/ . - Avila C, Bright R, Gutierrez J, et al. Guatemala Health System Assessment 2015. Bethesda, MD: Health Finance & Governance Project, Abt Associates Inc; 2015.
- Instituto Guatemalteco de Seguridad Social (IGSS). Boletín estadístico de afiliación 2021. Guatemala City, Guatemala: IGSS; 2021.
- Pinnock H, Barwick M, Carpenter CR, et al. Standards for reporting implementation studies (StaRI) statement. BMJ. 2017; 356:i6795. DOI: 10.1136/bmj.i6795
- Riley L, Guthold R, Cowan M, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016; 106(1):74–8. DOI: 10.2105/AJPH.2015.302962
- Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet; 2021.
- Collaboration NCDRF. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024; 404(10467):2077–93. DOI: 10.1016/S0140-6736(24)02317-1
- MSPAS. Encuesta Nacional de Prevalencia de Enfermedades No Transmisibles y sus Factores de Riesgo En población de 18 años o más. Dominio I: Urbano Metropolitana, Departamento de Guatemala, diciembre 2015; 2018.
- Pickens CM, Flores-Ayala R, Addo OY, et al. Prevalence and predictors of high blood pressure among women of reproductive age and children aged 10 to 14 years in Guatemala. Prev Chronic Dis. 2020; 17:
E66 . DOI: 10.5888/pcd17.190403 - Steinbrook E, Flood D, Barnoya J, Montano CM, Miller AC, Rohloff P. Prevalence of hypertension, diabetes, and other cardiovascular disease risk factors in two indigenous municipalities in rural Guatemala: A population-representative survey. Global Heart. 2022; 17(1). DOI: 10.5334/gh.1171
- Ministerio de Salud Pública y Asistencia Social/Guatemala. Lineamientos para implementar intervenciones v seleccionar medicamentos para atender las morbilidades de enfermedades cronicas no transmisibles. Guatemala City: MSPAS; 2023.
- Ministerio de Salud Pública Asistencia Social. Normas de atención salud integral para primero y segundo nivel 2018. MSPAS; 2018.
- Paniagua-Avila A, Fort MP, Glasgow RE, et al. Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial. Trials. 2020; 21(1):509. DOI: 10.1186/s13063-020-04345-8
- Wellmann IA, Rodriguez JJ, Batzin B, et al. Reach and effectiveness of a HEARTS hypertension pilot project in Guatemala. Rev Panam Salud Publica. 2024; 48:
e100 . DOI: 10.26633/RPSP.2024.100 - Anson A, Ramay B, Esparza AR, Bero L. Availability, prices and affordability of the World Health Organization’s essential medicines for children in Guatemala. Global Health. 2012; 8. DOI: 10.1186/1744-8603-8-22
- Pan American Health Organization. Implementarán iniciativa Hearts para la prevención y el control de las enfermedades cardiovasculares (ECV) en Guatemala; 2022 [cited 2024 February 27]. Available from:
https://www.paho.org/es/noticias/11-11-2022-implementaran-iniciativa-hearts-para-prevencion-control-enfermedades . - American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024. Diabetes Care. 2024; 47(Suppl 1):S158–S78. DOI: 10.2337/dc24-S009
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018; 71(19):e127–e248. DOI: 10.1161/HYP.0000000000000076
- Asociación Latinoamericana de Diabetes (ALAD). Guías ALAD sobre el diagnóstico, control y tratamiento de la diabetes mellitus tipo 2 con medicina basada en evidencia edición 2019. Revista de la ALAD; 2019.
- Task Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017; 35(8):1529–45. DOI: 10.1097/HJH.0000000000001418
- WHO. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021.
- Nigeria Ministry of Health, University of Oslo, WHO Nigeria, Resolve to Save Lives. DHIS2 Package for Hypertension Control Programs [cited 2023 February 4]. Available from:
https://s3.eu-west-1.amazonaws.com/content.dhis2.org/Publications/DHIS2+for+Hypertension+Control+Programs.pdf . - Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2):377–81. DOI: 10.1016/j.jbi.2008.08.010
- WHO. HEARTS technical package for cardiovascular disease management in primary health care: systems for monitoring. Geneva: World Health Organization; 2018.
- Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011; 38(2): 65–76. DOI: 10.1007/s10488-010-0319-7
- Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017; 12(1):108. DOI: 10.1186/s13012-017-0635-3
- WHO.
HEARTS-D: Diagnosis and management of type 2 diabetes . Geneva: World Health Organization; 2020. - Center for Public Health system science. Program sustainability assessment tool v2. St Louis, MO: Washington University; 2013 [cited 2024 April 24]. Available from:
https://sustaintool.org/wp-content/uploads/2016/12/Sustainability-ToolV2_w-scoring_12.11.13.pdf . - Luke DA, Calhoun A, Robichaux CB, Elliott MB, Moreland-Russell S. The program sustainability assessment tool: A new instrument for public health programs. Prev Chronic Dis. 2014; 11:130184. DOI: 10.5888/pcd11.130184
- Center for Public Health Systems Science.
Clinical sustainability assessment tool . St Louis, MO: Washington University; 2019 [cited 2023 April 26]. Available from:https://sustaintool.org/wp-content/uploads/2020/01/CSAT-tool-and-scoring_1.14.20.pdf . - Malone S, Prewitt K, Hackett R, et al. The clinical sustainability assessment tool: Measuring organizational capacity to promote sustainability in healthcare. Implement Sci Commun. 2021; 2(1):77. DOI: 10.1186/s43058-021-00181-2
- Brooke J. SUS-A quick and dirty usability scale. Usability Evaluation in Industry. 1996; 189(194):4–7.
- Sevilla-Gonzalez MDR, Moreno Loaeza L, Lazaro-Carrera LS, et al. Spanish version of the system usability scale for the assessment of electronic tools: development and validation. JMIR Hum Factors. 2020; 7(4):
e21161 . DOI: 10.2196/21161 - Derington CG, Bress AP, Moran AE, et al. Antihypertensive medication regimens used in the systolic blood pressure intervention trial. Hypertension. 2023; 80(3):590–7. DOI: 10.1161/HYPERTENSIONAHA.122.20373
- Alexopoulos AS, Yancy WS, Edelman D, et al. Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. Chronic Illn. 2021; 17(4):451–62. DOI: 10.1177/1742395319884096
- Mayer SB, Jeffreys AS, Olsen MK, McDuffie JR, Feinglos MN, Yancy WS,
Jr. . Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. Diabetes Obes Metab. 2014; 16(1):90–3. DOI: 10.1111/dom.12191 - WHO. Service availability and readiness assessment (SARA): an annual monitoring system for service delivery: reference manual. Genvea: World Health Organization; 2013.
- WHO. HEARTS Technical package for cardiovascular disease management in primary health care: implementation guide. Geneva: World Health Organization; 2018.
- Linden A. Conducting interrupted time-series analysis for single-and multiple-group comparisons. The Stata Journal. 2015; 15(2):480–500. DOI: 10.1177/1536867X1501500208
- Fort MP, Mundo W, Paniagua-Avila A, et al. Hypertension in Guatemala’s public primary care system: a needs assessment using the health system building blocks framework. BMC Health Serv Res. 2021; 21(1):908. DOI: 10.1186/s12913-021-06889-0
- Paniagua-Avila A, Shelton RC, Figueroa JC, et al. Assessing the implementation of a multi-component hypertension program in a Guatemalan under-resourced dynamic context: An application of the RE-AIM/PRISM extension for sustainability and health equity. Implementation Science Communications. 2024; 5(1). DOI: 10.1186/s43058-024-00560-5
- Burka D, Gupta R, Moran AE, et al. Keep it simple: Designing a user-centred digital information system to support chronic disease management in low/middle-income countries. BMJ Health & Care Informatics. 2023; 30(1). DOI: 10.1136/bmjhci-2022-100641
- Ordunez P, Campbell NRC, DiPette DJ, et al. HEARTS in the Americas: Targeting health system change to improve population hypertension control. Curr Hypertens Rep. 2024; 26(4):141–56. DOI: 10.1007/s11906-023-01286-w
- Cohn J, Bygrave H, Roberts T, Khan T, Ojji D, Ordunez P. Addressing failures in achieving hypertension control in low- and middle-income settings through simplified treatment algorithms. Global Heart. 2022; 17(1). DOI: 10.5334/gh.1082
- Ye J, Orji IA, Baldridge AS, et al. Characteristics and patterns of retention in hypertension care in primary care settings from the hypertension treatment in nigeria program. JAMA Netw Open. 2022; 5(9):
e2230025 . DOI: 10.1001/jamanetworkopen.2022.30025 - Ye J, Orji IA, Birkett MA, et al. Community-based participatory research and system dynamics modeling for improving retention in hypertension care. JAMA Netw Open. 2024; 7(8):
e2430213 . DOI: 10.1001/jamanetworkopen.2024.30213 - World Diabetes Foundation. Implementing a national diabetes and hypertension care model in Guatemala (WDF23–1915); 2024 [cited 2024 November 14]. Available from:
https://www.worlddiabetesfoundation.org/what-we-do/projects/wdf23-1915/ . - Abrar A, Hu X, Akhtar J, et al. Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial. Heart; 2024. DOI: 10.1136/heartjnl-2024-324253
- Baldridge AS, Aluka-Omitiran K, Orji IA, et al. Hypertension treatment in nigeria (HTN) program: Rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial. Implement Sci Commun. 2022; 3(1):84. DOI: 10.1186/s43058-022-00328-9
DOI: https://doi.org/10.5334/gh.1397 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 7, 2024
Accepted on: Jan 15, 2025
Published on: Jan 31, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Irmgardt Alicia Wellmann, Luis Fernando Ayala, Taryn M. Valley, Vilma Irazola, Mark D. Huffman, Michele Heisler, Peter Rohloff, Rocío Donis, Eduardo Palacios, Manuel Ramírez-Zea, David Flood, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.